04.01.2026, 595 Zeichen

Valneva: Valneva SE, a specialty vaccine company, and Serum Institute of India, a Cyrus Poonawalla Group company today announced that they have mutually agreed to discontinue their license agreement for Valneva's single-shot chikungunya vaccine. Valneva's strategic intent in regaining full rights is to assume direct control over its supply chain and commercialization for endemic high-risk countries, thereby accelerating access for regions most affected by the disease.
Valneva: weekly performance: 5.10%

(From the 21st Austria weekly https://www.boerse-social.com/21staustria (31/12/2025)

Christian Drastil: Wiener Börse Plausch

Inside Umbrella powered by wikifolio 04/26: Diese 8 Titel bilden Ritschy`s Fokus auf Öl, Gas und LNG ab, Spoiler Umbrella Austria

Bildnachweis

Aktien auf dem Radar:DO&CO, Zumtobel, AT&S, Semperit, Austriacard Holdings AG, Mayr-Melnhof, Rosenbauer, SBO, Marinomed Biotech, Addiko Bank, Amag, Andritz, Bawag, CA Immo, Erste Group, FACC, Kapsch TrafficCom, Lenzing, OMV, Palfinger, Bajaj Mobility AG, Porr, RBI, Strabag, Uniqa, Verbund, voestalpine, Wienerberger, Wiener Privatbank, BKS Bank Stamm, BTV AG.

---